Cargando…

A Clinical Study on the Treatment of Recurrent Chiari (Type I) Malformation with Syringomyelia Based on the Dynamics of Cerebrospinal Fluid

OBJECTIVE: Combining the dynamics of cerebrospinal fluid, our study investigates the clinical effects of syringomyelia after the combination of fourth ventricle-subarachnoid shunt (FVSS) for recurrent Chiari (type I) malformations after cranial fossa decompression (foramen magnum decompression (FMD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Lou, Yongli, Yang, Jichao, Gu, Haoyuan, Xu, Guanghua, Ji, Shanfeng, Xu, Chi, Liu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584687/
https://www.ncbi.nlm.nih.gov/pubmed/36277900
http://dx.doi.org/10.1155/2022/9770323
_version_ 1784813325257801728
author Lou, Yongli
Yang, Jichao
Gu, Haoyuan
Xu, Guanghua
Ji, Shanfeng
Xu, Chi
Liu, Yong
author_facet Lou, Yongli
Yang, Jichao
Gu, Haoyuan
Xu, Guanghua
Ji, Shanfeng
Xu, Chi
Liu, Yong
author_sort Lou, Yongli
collection PubMed
description OBJECTIVE: Combining the dynamics of cerebrospinal fluid, our study investigates the clinical effects of syringomyelia after the combination of fourth ventricle-subarachnoid shunt (FVSS) for recurrent Chiari (type I) malformations after cranial fossa decompression (foramen magnum decompression (FMD)). METHODS: From December 2018 to December 2020, 15 patients with recurrent syringomyelia following posterior fossa decompression had FVSS surgery. Before and after the procedure, the clinical and imaging data of these individuals were retrospectively examined. RESULTS: Following FVSS, none of the 15 patients experienced infection, nerve injury, shunt loss, or obstruction. 13 patients improved dramatically after surgery, while 2 patients improved significantly in the early postoperative period, but the primary symptoms returned 2 months later. The Japanese Orthopedic Association (JOA) score was 12.67 ± 3.95, which was considerably better than preoperatively (t = 3.69, P0.001). The MRI results revealed that the cavities in 13 patients were reduced by at least 50% compared to the cavities measured preoperatively. The shrinkage rate of syringomyelia was 86.67% (13/15). One patient's cavities nearly vanished following syringomyelia. The size of the cavity in the patient remain unchanged, and the cavity's maximal diameter was significantly smaller than the size measured preoperatively (P < 0.001) PC-MRI results indicated that the peak flow rate of cerebrospinal fluid at the central segment of the midbrain aqueduct and the foramen magnum in patients during systole and diastole were significantly reduced after surgery (P < 0.05). CONCLUSION: After posterior fossa decompression, FVSS can effectively restore the smooth circulation of cerebrospinal fluid and alleviate clinical symptoms in patients with recurrent Chiari (type I) malformation and syringomyelia. It is a highly effective way of treatment.
format Online
Article
Text
id pubmed-9584687
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-95846872022-10-21 A Clinical Study on the Treatment of Recurrent Chiari (Type I) Malformation with Syringomyelia Based on the Dynamics of Cerebrospinal Fluid Lou, Yongli Yang, Jichao Gu, Haoyuan Xu, Guanghua Ji, Shanfeng Xu, Chi Liu, Yong Biomed Res Int Research Article OBJECTIVE: Combining the dynamics of cerebrospinal fluid, our study investigates the clinical effects of syringomyelia after the combination of fourth ventricle-subarachnoid shunt (FVSS) for recurrent Chiari (type I) malformations after cranial fossa decompression (foramen magnum decompression (FMD)). METHODS: From December 2018 to December 2020, 15 patients with recurrent syringomyelia following posterior fossa decompression had FVSS surgery. Before and after the procedure, the clinical and imaging data of these individuals were retrospectively examined. RESULTS: Following FVSS, none of the 15 patients experienced infection, nerve injury, shunt loss, or obstruction. 13 patients improved dramatically after surgery, while 2 patients improved significantly in the early postoperative period, but the primary symptoms returned 2 months later. The Japanese Orthopedic Association (JOA) score was 12.67 ± 3.95, which was considerably better than preoperatively (t = 3.69, P0.001). The MRI results revealed that the cavities in 13 patients were reduced by at least 50% compared to the cavities measured preoperatively. The shrinkage rate of syringomyelia was 86.67% (13/15). One patient's cavities nearly vanished following syringomyelia. The size of the cavity in the patient remain unchanged, and the cavity's maximal diameter was significantly smaller than the size measured preoperatively (P < 0.001) PC-MRI results indicated that the peak flow rate of cerebrospinal fluid at the central segment of the midbrain aqueduct and the foramen magnum in patients during systole and diastole were significantly reduced after surgery (P < 0.05). CONCLUSION: After posterior fossa decompression, FVSS can effectively restore the smooth circulation of cerebrospinal fluid and alleviate clinical symptoms in patients with recurrent Chiari (type I) malformation and syringomyelia. It is a highly effective way of treatment. Hindawi 2022-10-13 /pmc/articles/PMC9584687/ /pubmed/36277900 http://dx.doi.org/10.1155/2022/9770323 Text en Copyright © 2022 Yongli Lou et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Lou, Yongli
Yang, Jichao
Gu, Haoyuan
Xu, Guanghua
Ji, Shanfeng
Xu, Chi
Liu, Yong
A Clinical Study on the Treatment of Recurrent Chiari (Type I) Malformation with Syringomyelia Based on the Dynamics of Cerebrospinal Fluid
title A Clinical Study on the Treatment of Recurrent Chiari (Type I) Malformation with Syringomyelia Based on the Dynamics of Cerebrospinal Fluid
title_full A Clinical Study on the Treatment of Recurrent Chiari (Type I) Malformation with Syringomyelia Based on the Dynamics of Cerebrospinal Fluid
title_fullStr A Clinical Study on the Treatment of Recurrent Chiari (Type I) Malformation with Syringomyelia Based on the Dynamics of Cerebrospinal Fluid
title_full_unstemmed A Clinical Study on the Treatment of Recurrent Chiari (Type I) Malformation with Syringomyelia Based on the Dynamics of Cerebrospinal Fluid
title_short A Clinical Study on the Treatment of Recurrent Chiari (Type I) Malformation with Syringomyelia Based on the Dynamics of Cerebrospinal Fluid
title_sort clinical study on the treatment of recurrent chiari (type i) malformation with syringomyelia based on the dynamics of cerebrospinal fluid
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584687/
https://www.ncbi.nlm.nih.gov/pubmed/36277900
http://dx.doi.org/10.1155/2022/9770323
work_keys_str_mv AT louyongli aclinicalstudyonthetreatmentofrecurrentchiaritypeimalformationwithsyringomyeliabasedonthedynamicsofcerebrospinalfluid
AT yangjichao aclinicalstudyonthetreatmentofrecurrentchiaritypeimalformationwithsyringomyeliabasedonthedynamicsofcerebrospinalfluid
AT guhaoyuan aclinicalstudyonthetreatmentofrecurrentchiaritypeimalformationwithsyringomyeliabasedonthedynamicsofcerebrospinalfluid
AT xuguanghua aclinicalstudyonthetreatmentofrecurrentchiaritypeimalformationwithsyringomyeliabasedonthedynamicsofcerebrospinalfluid
AT jishanfeng aclinicalstudyonthetreatmentofrecurrentchiaritypeimalformationwithsyringomyeliabasedonthedynamicsofcerebrospinalfluid
AT xuchi aclinicalstudyonthetreatmentofrecurrentchiaritypeimalformationwithsyringomyeliabasedonthedynamicsofcerebrospinalfluid
AT liuyong aclinicalstudyonthetreatmentofrecurrentchiaritypeimalformationwithsyringomyeliabasedonthedynamicsofcerebrospinalfluid
AT louyongli clinicalstudyonthetreatmentofrecurrentchiaritypeimalformationwithsyringomyeliabasedonthedynamicsofcerebrospinalfluid
AT yangjichao clinicalstudyonthetreatmentofrecurrentchiaritypeimalformationwithsyringomyeliabasedonthedynamicsofcerebrospinalfluid
AT guhaoyuan clinicalstudyonthetreatmentofrecurrentchiaritypeimalformationwithsyringomyeliabasedonthedynamicsofcerebrospinalfluid
AT xuguanghua clinicalstudyonthetreatmentofrecurrentchiaritypeimalformationwithsyringomyeliabasedonthedynamicsofcerebrospinalfluid
AT jishanfeng clinicalstudyonthetreatmentofrecurrentchiaritypeimalformationwithsyringomyeliabasedonthedynamicsofcerebrospinalfluid
AT xuchi clinicalstudyonthetreatmentofrecurrentchiaritypeimalformationwithsyringomyeliabasedonthedynamicsofcerebrospinalfluid
AT liuyong clinicalstudyonthetreatmentofrecurrentchiaritypeimalformationwithsyringomyeliabasedonthedynamicsofcerebrospinalfluid